GlobeNewswire EN Nachrichten

 

Nero 2003 Ferrari Enzo Leads Collection at $15,185,000 | 1988 Porsche 959 Sport Achieves New Record for the Model at $5,505,000 | 2021 Ferrari Monza SP2 Sets New Benchmark at $4,955,000 | 2017 Ferrari F12tdf Reaches New Heights at $4,185,000 | 2015 Porsche 918 Spyder Sells for World Record Price at $2,975,000 | Outside the Collection, Paint-to-Sample 2005 Porsche Carrera GT Doubles Previous Record at $6,715,000 Nero 2003 Ferrari Enzo Leads Collection at $15,185,000 | 1988 Porsche 959 Sport Achieves New Record for the Model at $5,505,000 | 2021 Ferrari Monza SP2 Sets New Benchmark at $4,955,000 | 2017 Ferrari F12tdf Reaches New Heights at $4,185,000 | 2015 Porsche 918 Spyder Sells for World Record Price at $2,975,000 | Outside the Collection, Paint-to-Sample 2005 Porsche Carrera GT Doubles Previous Record at $6,715,000...

NEW YORK, March 06, 2026 (GLOBE NEWSWIRE) --  AMC Networks Inc. (“AMC Networks” or the “Company”) (Nasdaq: AMCX) announced today the expiration and results of the previously announced and extended consent solicitation (the “Consent Solicitation”) soliciting consents (“Consents”) from the holders of its existing 10.50% Senior Secured Notes due 2032 (the “Notes”) to amend the indenture governing the Notes to (1) amend the covenant that limits restricted payments in order to permit buybacks, purchases, redemptions, retirements or other acquisitions of AMC Networks Inc.'s equity interests in an aggregate amount not to exceed $50,000,000; (2) revise the covenant that limits transfers or licenses of certain trademarks to unrestricted subsidiaries to only permit transfers of non-exclusive licenses; and (3) restrict investments in unrestricted subsidiaries made pursuant to the definition of “Permitted Investments” to certain specified clauses in such definition (the “Amendments”)....

NEW YORK, March 06, 2026 (GLOBE NEWSWIRE) -- AMC Networks Inc. (“AMC Networks” or the “Company”) (Nasdaq: AMCX) today announced the early participation and consent results in connection with its previously announced (i) exchange offer (the “Exchange Offer”) to Eligible Holders (as defined below) to exchange any and all of its outstanding 10.25% Senior Secured Notes due 2029 (the “Old Notes”) for its newly-issued 10.50% Senior Secured Notes due 2032 (the “New Notes”), and (ii) the solicitation of consents (the “Consent Solicitation”) from holders of the Old Notes with respect to the amendment (the “Proposed Amendment”) to the indenture governing the Old Notes (the “Old Notes Indenture”) described below, on the terms and subject to the conditions set forth in a Confidential Offering Memorandum and Consent Solicitation Statement, dated as of February 23, 2026 (the “Offering Memorandum”). Capitalized terms not defined herein shall have the respective meanings ascribed to ...

OCALA, Fla., March 06, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) – AIM ImmunoTech Inc. (“AIM” or the “Company”), an immuno-pharma company focused on the research and development of its lead product, Ampligen® (rintatolimod), for the treatment of late-stage pancreatic cancer – a lethal and unmet global health problem – announced today the closing of its previously announced rights offering (the “Rights Offering”). The Rights Offering resulted in total subscriptions of approximately $1.8 million....

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES...

Each Lisata stockholder to receive $5.00 per share in cash payable at closing plus one contingent value right for a potential additional cash payment of $1.00 per share...

CHICAGO, March 06, 2026 (GLOBE NEWSWIRE) -- XAI Octagon Floating Rate & Alternative Income Trust (NYSE: XFLT) (the “Trust”) today announced that its Board of Trustees has approved the implementation of a 1-for-5 reverse stock split (the “Reverse Stock Split”) of the Trust's common shares of beneficial interest, par value $0.01 per share (the “Common Shares”)....

6 March 2026, 23:55 CET...

BOSTON, March 06, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that, effective February 2, 2026, the Compensation Committee of Tango Therapeutics' Board of Directors granted a non-qualified stock option to purchase 367,500 shares of its common stock and 60,000 restricted stock units (RSUs) to a new employee under Tango Therapeutics' 2023 Inducement Plan....

Um den gesamten Artikel unter globenewswire.com zu lesen, klicken Sie bitte auf die Überschrift...

VANCOUVER, British Columbia, March 06, 2026 (GLOBE NEWSWIRE) -- Canfor Pulp Products Inc. (TSX: CFX) (“Canfor Pulp” or the “Company”) is pleased to announce that at the special meeting (the “Company Meeting”) of the holders of common shares (the “Shareholders”) in the capital of the Company (the “Common Shares”) held earlier today, the Shareholders voted in favour of approving the special resolution authorizing the previously announced arrangement (the “Arrangement”) whereby Canfor Corporation (the “Purchaser”) will acquire all of the issued and outstanding Common Shares that it and its affiliates do not already own by way of a statutory plan of arrangement (the “Plan of Arrangement”)...

Includes Annual Financial Statements, MD&A and 2025 Sustainability and Social Impact Disclosure Includes Annual Financial Statements, MD&A and 2025 Sustainability and Social Impact Disclosure...

VANCOUVER, British Columbia, March 06, 2026 (GLOBE NEWSWIRE) -- Methanex Corporation (TSX:MX) (Nasdaq:MEOH) today released its 2025 Sustainability Report to share its progress on the sustainability topics that are most material to the company and its stakeholders....

TORONTO, March 06, 2026 (GLOBE NEWSWIRE) -- Partners Value Investments Inc. (the “Company”) (TSXV: PVF.WT, PVF.PR.V, PVF.A) today issues a reminder that the outstanding share purchase warrants issued on November 27, 2023 (the "Warrants") which are exercisable into non-voting exchangeable shares (the “Exchangeable Shares”) of the Company (PVF.A) will expire on June 30, 2026 in accordance with their terms....

Vancouver, BC, March 06, 2026 (GLOBE NEWSWIRE) -- Uriel Gas Holdings Corp. (“Uriel” or the “Company”) (CSE: UGH), announces the resignation of Daniel Custock as Chief Executive Officer and director of the Company....

MONTRÉAL, March 06, 2026 (GLOBE NEWSWIRE) -- Bombardier Inc. (“Bombardier”) today announced that it has redeemed all remaining outstanding US$250,000,000 aggregate principal amount of its 6.000% Senior Notes due 2028 (the “Redemption Notes”), as set forth in the notice of redemption issued February 19, 2026. This debt redemption was funded using cash from Bombardier's balance sheet. Payment of the redemption price and surrender of the Redemption Notes for redemption are being made through the facilities of the Depository Trust Company in accordance with the applicable procedures of the Depository Trust Company....

GUADALAJARA, Mexico, March 06, 2026 (GLOBE NEWSWIRE) -- Grupo Aeroportuario del Pacífico, S.A.B. de C.V., (NYSE: PAC; BMV: GAP) (“the Company” or “GAP”) announces preliminary terminal passenger traffic figures for February 2026, compared with February 2025....

Hong Kong, March 06, 2026 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM), a leading Biotechnology company, today announced that it has received a notification from the Nasdaq Stock Market LLC dated March 5, 2026 regarding non-compliance with the minimum bid price requirement of $1 per share, as per Nasdaq Listing Rule 5550(a)(2)....

CAMBRIDGE, Mass., March 06, 2026 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that the company granted non-statutory stock options to one new employee. Fulcrum granted stock options to purchase shares of the company's common stock pursuant to the company's 2022 Inducement Stock Incentive Plan, as amended, or the plan, as an inducement material to the new employee entering into employment with Fulcrum in accordance with Nasdaq Listing Rule 5635(c)(4)....

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, March 06, 2026 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that on March 2, 2026 (the “Grant Date”), ORIC granted a total of 14,800 non-qualified stock options and 2,400 restricted stock units to one new non-executive employee who began their employment with ORIC in February 2026....